SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Contact Us
Diabetes
Products
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Skip Navigation Links
Home
»
Investors
»
Press Releases
2020
2019
2018
2017
2016
2015
2014
2013
Former Diamyd Medical
Data pager
Data pager
1
2
Show:
PageSizeComboBox
select
10
20
50
100
150
2 pages
Press Releases
Data pager
Data pager
1
2
Show:
PageSizeComboBox
select
10
20
50
100
150
2 pages
6/24/2020
Quarterly Report III 19/20
5/27/2020
Results from clinical trial with Diamyd
®
in children at high risk for type 1 diabetes
5/4/2020
Promising findings from the first part of a clinical trial with Remygen
®
4/24/2020
Japan grants patent for intralymphatic administration of the diabetes vaccine Diamyd
®
4/16/2020
Diamyd Medical opens up for vaccine manufacturing in Umeå, Sweden
4/14/2020
The European Patent Office grants patent for intralymphatic administration of the diabetes vaccine Diamyd
®
3/25/2020
Quarterly Report II 19/20
3/2/2020
New trial with Diamyd
®
in autoimmune diabetes has started recruiting patients in Norway
2/5/2020
Diamyd Medical enters agreement to facilitate transition of manufacturing
2/3/2020
Diamyd Medical to present this week at LSX World Congress and at Swiss-Nordic Bio 2020
Order GAD for preclinical research
ORDER
©
Privacy Policy
|
Cookie Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research